CD274 and small cell lung carcinoma: This research aims to assess the effectiveness and safety of integrating PD‐1/PD‐L1 inhibitors with chemotherapy for treating patients with small‐cell lung cancer (SCLC), and investigates the potential clinical benefits of these inhibitors within the SCLC treatment framework.